Combined Synopsis/Solicitation & Notice of Intent to Sole Source to Tradespace for Subscription
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
FDA OFFICE OF ACQ GRANT SVCS
Contract Value
Not provided
Codes & Classification
Solicitation Number
75F40126Q00438
NAICS
513210 - Software Publishers
Classification Code
DA10
Additional Details
Documents2
The Food and Drug Administration (FDA), operating under the Department of Health and Human Services, has issued an updated Combined Synopsis/Solicitation and Notice of Intent to Sole Source for the procurement of a subscription-based search engine service. This notice, identified by procurement number 75F40126Q00438, supersedes the original notice dated September 18, 2026, and is now effective as of September 21, 2026. The procurement is managed by the FDA Office of Acquisition and Grant Services, with the primary point of contact being Min Jie Zeng ([email protected]).
The primary objective of this procurement is to secure access to a comprehensive search engine platform that provides standard market intelligence, commercialization insights, and intellectual property (IP) analytics. In addition to the core subscription, the requirement encompasses associated training and technical support services to ensure effective utilization of the platform by FDA personnel. The intended outcome is to enhance the FDA’s capabilities in market research, technology commercialization, and IP analysis, supporting its mission to protect and promote public health.
This opportunity is classified under NAICS code 513210 (Software Publishers, 2022 version) and Product Service Code DA10, indicating a focus on software solutions and related services. The place of performance is specified as Silver Spring, Maryland, United States.
The procurement is being conducted as a sole source acquisition, with no set-aside for small businesses or other socioeconomic categories. This approach reflects the Government’s determination that only one source—Tradespace—can meet the agency’s requirements for the specified subscription and support services. Contractors should note that this is not a competitive solicitation; rather, it is a notice of the Government’s intent to award on a sole source basis, in accordance with applicable federal regulations.
Interested parties may review the full notice and any associated attachments via the official SAM.gov opportunity listing (Opportunity ID: 47abb7f9ce68401192697abc9a0163ed). The notice remains active, with a response deadline set for September 22, 2026, at 19:09.
In summary, this procurement seeks to provide the FDA with a robust, subscription-based search engine platform, complete with market intelligence, commercialization, and IP analytics features, as well as comprehensive training and technical support. The acquisition is managed by the FDA Office of Acquisition and Grant Services in Silver Spring, Maryland, and is being executed as a sole source action with no set-aside provisions.